SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Health In Tech, Inc. (NASDAQ:HIT)

US · Delayed Price · Currency is USD
0.76-0.05 (-6.11%)
 
Market Cap40.95M-78.2%
Revenue (ttm)32.83M+23.0%
Net Income-3.95M-390.2%
EPS-0.07-395.3%
Shares Out53.86M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume60,816
Open0.78
Previous Close0.81
Day's Range0.74 - 0.79
52-Week Range0.65 - 3.57
Beta2.81
AnalystsBuy
Price Target3.50(+360.28%)
Earnings DateNov 9, 2026
-7.40% (1D)
No price history available.
Insider Score
––Not scored
HIT Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

About HIT

Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses. Health In Tech further supports healthcare administration with its "health intelligence" (HI) card, which streamlines the management of medical records and claims. Complementing this is the HI performance network, an extensive series of medical facilities that utilize Medicare-based reimbursement pricing. This organization was established in 2014 and its principal offices are located in Stuart, Florida.

Address
701 S. Colorado Ave, Stuart, FL, 34994, US
Market Cap
41 million
Employees
89
Industrial Classification
Software - Application

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$37.70K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-6.11%
5 Days
+2.76%
1 Month
-18.34%
6 Months
-44.09%
1 Year
-78.21%

$HIT stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in HIT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by HIT's directors and management

Net Shares Purchased by Insiders−50k−25k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

HIT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New HIT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to HIT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in HIT

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$389.76K
VXFVanguard Extended Market ETF$277.91K
IWCiShares Micro-Cap ETF$48.03K

Estimated from each fund’s disclosed top holdings × AUM

HIT Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for HIT is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from HIT’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
4
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.